1. 183TiPNeoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial. (23rd October 2018) Authors: Ignatiadis, M; Brandao, M; Maetens, M; Ponde, N; Martel, S; Drisis, S; Veys, I; Mazy, S; Bollue, E; Neven, P; Duhoux, F P; Chapiro, J; Awada, A H; Besse-Hammer, T; Paesmans, M; Piccart, M; Vuylsteke, P; Sotiriou, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P107 Embryonal rhabdomyosarcoma of uterus in adult women: a systematic review and survival analysis of 116 patients. (1st November 2019) Authors: Pop, F-C; Stanciu Pop, C; Moreau, M; Jungels, C; Chintinne, M; Artigas, GC; Larsimont, D; Veys, I Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗